The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells

Veterinary Immunology and Immunopathology

Volumn 143, Issue 1-2, 2011, Pages 87-107

  Mackenzie Dyck, Sarah ^a,b   Attah Poku, Sam ^a   Juillard, Veronique ^c   Babiuk, Lorne A ^d   Hurk, Sylvia van Drunen Littel van den ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antigen presenting cell; Antimicrobial peptide; Bos taurus; Cell recruitment; Host defense peptide

Indexed keywords

B7 ANTIGEN; BOVINE NEUTROPHIL BETA DEFENSIN 1; BOVINE NEUTROPHIL BETA DEFENSIN 10; BOVINE NEUTROPHIL BETA DEFENSIN 11; BOVINE NEUTROPHIL BETA DEFENSIN 12; BOVINE NEUTROPHIL BETA DEFENSIN 13; BOVINE NEUTROPHIL BETA DEFENSIN 2; BOVINE NEUTROPHIL BETA DEFENSIN 3; BOVINE NEUTROPHIL BETA DEFENSIN 4; BOVINE NEUTROPHIL BETA DEFENSIN 5; BOVINE NEUTROPHIL BETA DEFENSIN 6; BOVINE NEUTROPHIL BETA DEFENSIN 7; BOVINE NEUTROPHIL BETA DEFENSIN 8; BOVINE NEUTROPHIL BETA DEFENSIN 9; CD1 ANTIGEN; CD86 ANTIGEN; CHEMOTACTIC PEPTIDE; DEFENSIN; MANNOSE RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CATTLE; CELL MATURATION; CHEMOTAXIS; DENDRITIC CELL; ESCHERICHIA COLI; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CATTLE; CELL DIFFERENTIATION; CHEMOTAXIS; DENDRITIC CELLS; DISULFIDES; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; SEQUENCE HOMOLOGY, AMINO ACID; SKIN;

BOS; BOS TAURUS; BOVINAE; MURINAE; MUS;

EID: 79961020726     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.028     Document Type: Article

References (115)

1. Ahmed A.K., Schaffer S.W., Wetlaufer D.B. Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers. J. Biol. Chem. 1975, 250:8477-8482.
2. Antcheva N., Morgera F., Creatti L., Vaccari L., Pag U., Pacor S., Shai Y., Sahl H.G., Tossi A. Artificial beta-defensin based on a minimal defensin template. Biochem. J. 2009, 421:435-447.
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Bauer F., Schweimer K., Kluver E., Conejo-Garcia J.R., Forssmann W.G., Rosch P., Adermann K., Sticht H. Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci. 2001, 10:2470-2479.
6. Bell D., Young J.W., Banchereau J. Dendritic cells. Adv. Immunol. 1999, 72:255-324.
7. Bensch K.W., Raida M., Magert H.J., Schulz-Knappe P., Forssmann W.G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995, 368:331-335.
8. Biragyn A., Belyakov I.M., Chow Y.H., Dimitrov D.S., Berzofsky J.A., Kwak L.W. DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 2002, 100:1153-1159.
9. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
10. Biragyn A., Surenhu M., Yang D., Ruffini P.A., Haines B.A., Klyushnenkova E., Oppenheim J.J., Kwak L.W. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 2001, 167:6644-6653.
11. Boniotto M., Antcheva N., Zelezetsky I., Tossi A., Palumbo V., Verga Falzacappa M.V., Sgubin S., Braida L., Amoroso A., Crovella S. A study of host defence peptide beta-defensin 3 in primates. Biochem. J. 2003, 374:707-714.
12. Caminschi I., Lahoud M.H., Shortman K. Enhancing immune responses by targeting antigen to DC. Eur. J. Immunol. 2009, 39:931-938.
13. Caux C., Vanbervliet B., Massacrier C., Ait-Yahia S., Vaure C., Chemin K., Dieu N.M.c., Vicari A. Regulation of dendritic cell recruitment by chemokines. Transplantation 2002, 73:S7-S11.
14. Cella M., Sallusto F., Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997, 9:10-16.
15. Circo R., Skerlavaj B., Gennaro R., Amoroso A., Zanetti M. Structural and functional characterization of hBD-1(Ser35), a peptide deduced from a DEFB1 polymorphism. Biochem. Biophys. Res. Commun. 2002, 293:586-592.
16. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 1996, 2:1122-1128.
17. de Leeuw E., Rajabi M., Zou G., Pazgier M., Lu W. Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 5. FEBS Lett. 2009, 583:2507-2512.
18. Dhople V., Krukemeyer A., Ramamoorthy A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta 2006, 1758:1499-1512.
19. Diamond G., Bevins C.L. beta-Defensins: endogenous antibiotics of the innate host defense response. Clin. Immunol. Immunopathol. 1998, 88:221-225.
20. Diamond G., Russell J.P., Bevins C.L. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5156-5160.
21. Diamond G., Zasloff M., Eck H., Brasseur M., Maloy W.L., Bevins C.L. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:3952-3956.
22. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998, 188:373-386.
23. Dutia B.M., Ross A.J., Hopkins J. Analysis of the monoclonal antibodies comprising WC6. Vet. Immunol. Immunopathol. 1993, 39:193-199.
24. Elahi S., Buchanan R.M., Attah-Poku S., Townsend H.G., Babiuk L.A., Gerdts V. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect. Immun. 2006, 74:2338-2352.
25. Falk W., Goodwin R.H., Leonard E.J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 1980, 33:239-247.
26. Ferrer M., Woodward C., Barany G. Solid-phase synthesis of bovine pancreatic trypsin inhibitor (BPTI) and two analogues. A chemical approach for evaluating the role of disulfide bridges in protein folding and stability. Int. J. Pept. Protein Res. 1992, 40:194-207.
27. Frevert C.W., Wong V.A., Goodman R.B., Goodwin R., Martin T.R. Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods 1998, 213:41-52.
28. Funderburg N., Lederman M.M., Feng Z., Drage M.G., Jadlowsky J., Harding C.V., Weinberg A., Sieg S.F. Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18631-18635.
29. Garcia J.R., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Adermann K., Forssmann U., Frimpong-Boateng A., Bals R., Forssmann W.G. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001, 15:1819-1821.
30. Gil-Torregrosa B.C., Lennon-Dumenil A.M., Kessler B., Guermonprez P., Ploegh H.L., Fruci D., van Endert P., Amigorena S. Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 2004, 34:398-407.
31. Glew E.J., Carr B.V., Brackenbury L.S., Hope J.C., Charleston B., Howard C.J. Differential effects of bovine viral diarrhoea virus on monocytes and dendritic cells. J. Gen. Virol. 2003, 84:1771-1780.
32. Gliddon D.R., Hope J.C., Brooke G.P., Howard C.J. DEC-205 expression on migrating dendritic cells in afferent lymph. Immunology 2004, 111:262-272.
33. Gliddon D.R., Howard C.J. CD26 is expressed on a restricted subpopulation of dendritic cells in vivo. Eur. J. Immunol. 2002, 32:1472-1481.
34. Good L., Nielsen P.E. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:2073-2076.
35. Graziani-Bowering G.M., Graham J.M., Filion L.G. A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes. J. Immunol. Methods 1997, 207:157-168.
36. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276:5707-5713.
37. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997, 90:3245-3287.
38. Hiratsuka T., Nakazato M., Date Y., Ashitani J., Minematsu T., Chino N., Matsukura S. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem. Biophys. Res. Commun. 1998, 249:943-947.
39. Hoover D.M., Chertov O., Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J. Biol. Chem. 2001, 276:39021-39026.
40. Hoover D.M., Wu Z., Tucker K., Lu W., Lubkowski J. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 2003, 47:2804-2809.
41. Hope J.C., Whelan A.O., Hewinson R.G., Vordermeier M., Howard C.J. Maturation of bovine dendritic cells by lipopeptides. Vet. Immunol. Immunopathol. 2003, 95:21-31.
42. Howard C.J., Brooke G.P., Werling D., Sopp P., Hope J.C., Parsons K.R., Collins R.A. Dendritic cells in cattle: phenotype and function. Vet. Immunol. Immunopathol. 1999, 72:119-124.
43. Howard C.J., Charleston B., Stephens S.A., Sopp P., Hope J.C. The role of dendritic cells in shaping the immune response. Anim. Health Res. Rev. 2004, 5:191-195.
44. Howard C.J., Collins R.A., Sopp P., Brooke G.P., Kwong L.S., Parsons K.R., Weynants V., Letesson J.J., Bembridge G.P. T-cell responses and the influence of dendritic cells in cattle. Adv. Vet. Med. 1999, 41:275-288.
45. Howard C.J., Hope J.C., Villarreal-Ramos B. Contribution of in vivo and ex vivo studies to understanding the role of antigen-presenting cells and T cell subsets in immunity to cattle diseases. Anim. Health Res. Rev. 2004, 5:1-13.
46. Howard C.J., Sopp P., Brownlie J., Kwong L.S., Parsons K.R., Taylor G. Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells. J. Immunol. 1997, 159:5372-5382.
47. Howard C.J., Sopp P., Brownlie J., Parsons K.R., Kwong L.S., Collins R.A. Afferent lymph veiled cells stimulate proliferative responses in allogeneic CD4+ and CD8+ T cells but not gamma delta TCR+ T cells. Immunology 1996, 88:558-564.
48. Huang Y., Babiuk L.A., van Drunen Littel-van den Hurk S. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J. Gen. Virol. 2005, 86:887-898.
49. Kluver E., Adermann K., Schulz A. Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system. J. Pept. Sci. 2006, 12:243-257.
50. Kluver E., Schulz-Maronde S., Scheid S., Meyer B., Forssmann W.G., Adermann K. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 2005, 44:9804-9816.
51. Kluver E., Schulz A., Forssmann W.G., Adermann K. Chemical synthesis of beta-defensins and LEAP-1/hepcidin. J. Pept. Res. 2002, 59:241-248.
52. Krishnakumari V., Sharadadevi A., Singh S., Nagaraj R. Single disulfide and linear analogues corresponding to the carboxy-terminal segment of bovine beta-defensin-2: effects of introducing the beta-hairpin nucleating sequence d-pro-gly on antibacterial activity and biophysical properties. Biochemistry 2003, 42:9307-9315.
53. Landi A., Babiuk L.A., van Drunen Littel-van den Hurk S. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J. Leukoc. Biol. 2007, 82:849-860.
54. Le Borgne M., Dubois B., Kaiserlian D. [Dendritic cells of mucosa and skin: " recruited for vaccination" ]. Med. Sci. (Paris) 2007, 23:819-825.
55. Lillard J....W., Boyaka P.N., Chertov O., Oppenheim J.J., McGhee J.R. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:651-656.
56. Luenser K., Ludwig A. Variability and evolution of bovine beta-defensin genes. Genes Immun. 2005, 6:115-122.
57. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 2002, 14:129-135.
58. MacHugh N.D., Bensaid A., Davis W.C., Howard C.J., Parsons K.R., Jones B., Kaushal A. Characterization of a bovine thymic differentiation antigen analogous to CD1 in the human. Scand. J. Immunol. 1988, 27:541-547.
59. Mandal M., Jagannadham M.V., Nagaraj R. Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activity. Peptides 2002, 23:413-418.
60. Manoj S., Griebel P.J., Babiuk L.A., van Drunen Littel-van den Hurk S. Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154. Immunology 2004, 112:328-338.
61. McKeever D.J., MacHugh N.D., Goddeeris B.M., Awino E., Morrison W.I. Bovine afferent lymph veiled cells differ from blood monocytes in phenotype and accessory function. J. Immunol. 1991, 147:3703-3709.
62. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide. Oligonucleotides 2003, 13:245-259.
63. Mirkovitch J., Konig A., Sauter K.S., Brcic M., Hope J.C., Howard C.J., Jungi T.W. Single-cell analysis divides bovine monocyte-derived dendritic cells into subsets expressing either high or low levels of inducible nitric oxide synthase. Vet. Immunol. Immunopathol. 2006, 114:1-14.
64. Morgera F., Pacor S., Creatti L., Antcheva N., Vaccari L., Tossi A. Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2. Biochem. J. 2011, 436(3):537-546.
65. Mwangi W., Brown W.C., Lewin H.A., Howard C.J., Hope J.C., Baszler T.V., Caplazi P., Abbott J., Palmer G.H. DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals. J. Immunol. 2002, 169:3837-3846.
66. Mwangi W., Brown W.C., Splitter G.A., Davies C.J., Howard C.J., Hope J.C., Aida Y., Zhuang Y., Hunter B.J., Palmer G.H. DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals. Clin. Vaccine Immunol. 2007, 14:304-311.
67. Mwangi W., Brown W.C., Splitter G.A., Zhuang Y., Kegerreis K., Palmer G.H. Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection. J. Leukoc. Biol. 2005, 78:401-411.
68. Nagase H., Yamaguchi M., Jibiki S., Yamada H., Ohta K., Kawasaki H., Yoshie O., Yamamoto K., Morita Y., Hirai K. Eosinophil chemotaxis by chemokines: a study by a simple photometric assay. Allergy 1999, 54:944-950.
69. Niyonsaba F., Iwabuchi K., Matsuda H., Ogawa H., Nagaoka I. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol. 2002, 14:421-426.
70. Niyonsaba F., Ogawa H., Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004, 111:273-281.
71. Norimatsu M., Chance V., Dougan G., Howard C.J., Villarreal-Ramos B. Live Salmonella enterica serovar Typhimurium (S. Typhimurium) elicit dendritic cell responses that differ from those induced by killed S. Typhimurium. Vet. Immunol. Immunopathol. 2004, 98:193-201.
72. Norimatsu M., Harris J., Chance V., Dougan G., Howard C.J., Villarreal-Ramos B. Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with Salmonella Typhimurium in a low-dose model in vitro. Immunology 2003, 108:55-61.
73. Oppenheim J.J., Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 2005, 17:359-365.
74. Pazgier M., Prahl A., Hoover D.M., Lubkowski J. Studies of the biological properties of human beta -defensin 1. J. Biol. Chem. 2007, 282:1819-1829.
75. Pinchuk L.M., Boyd B.L., Kruger E.F., Roditi I., Furger A. Bovine dendritic cells generated from monocytes and bone marrow progenitors regulate immunoglobulin production in peripheral blood B cells. Comp. Immunol. Microbiol. Infect. Dis. 2003, 26:233-249.
76. Presicce P., Giannelli S., Taddeo A., Villa M.L., Della Bella S. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J. Leukoc. Biol. 2009, 86:941-948.
77. Riegler S., Hebart H., Einsele H., Brossart P., Jahn G., Sinzger C. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 2000, 81:393-399.
78. Rohrl J., Yang D., Oppenheim J.J., Hehlgans T. Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3. J. Biol. Chem. 2008, 283:5414-5419.
79. Rohrl J., Yang D., Oppenheim J.J., Hehlgans T. Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 2010, 184:6688-6694.
80. Rohrl J., Yang D., Oppenheim J.J., Hehlgans T. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J. Biol. Chem. 2010, 285:7028-7034.
81. Routsias J.G., Karagounis P., Parvulesku G., Legakis N.J., Tsakris A. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains. Peptides 2010, 31:1654-1660.
82. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995, 182:389-400.
83. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., Forster R., Burgstahler R., Lipp M., Lanzavecchia A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 1999, 29:1617-1625.
84. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
85. Schonwetter B.S., Stolzenberg E.D., Zasloff M.A. Epithelial antibiotics induced at sites of inflammation. Science 1995, 267:1645-1648.
86. Schulz A., Kluver E., Schulz-Maronde S., Adermann K. Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. Biopolymers 2005, 80:34-49.
87. Scudiero O., Galdiero S., Cantisani M., Di Noto R., Vitiello M., Galdiero M., Naclerio G., Cassiman J.J., Pedone C., Castaldo G., Salvatore F. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob. Agents Chemother. 2010, 54:2312-2322.
88. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005, 6:551-557.
89. Selsted M.E., Tang Y.Q., Morris W.L., McGuire P.A., Novotny M.J., Smith W., Henschen A.H., Cullor J.S. Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J. Biol. Chem. 1993, 268:6641-6648.
90. Shen Y., Liu J., Estiu G., Isin B., Ahn Y.Y., Lee D.S., Barabasi A.L., Kapatral V., Wiest O., Oltvai Z.N. Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1082-1087.
91. Stebbing J., Savage P., Patterson S., Gazzard B. All for CD91 and CD91 for all. J. Antimicrob. Chemother. 2004, 53:1-3.
92. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9:271-296.
93. Steinman R.M., Pope M. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 2002, 109:1519-1526.
94. Struyf S., Proost P., Lenaerts J.P., Stoops G., Wuyts A., Van Damme J. Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1. Blood 2001, 97:2197-2204.
95. Tacken P.J., Torensma R., Figdor C.G. Targeting antigens to dendritic cells in vivo. Immunobiology 2006, 211:599-608.
96. Tarver A.P., Clark D.P., Diamond G., Russell J.P., Erdjument-Bromage H., Tempst P., Cohen K.S., Jones D.E., Sweeney R.W., Wines M., Hwang S., Bevins C.L. Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect. Immun. 1998, 66:1045-1056.
97. Taylor K., Barran P.E., Dorin J.R. Structure-activity relationships in beta-defensin peptides. Biopolymers 2008, 90:1-7.
98. Taylor K., Clarke D.J., McCullough B., Chin W., Seo E., Yang D., Oppenheim J., Uhrin D., Govan J.R., Campopiano D.J., MacMillan D., Barran P., Dorin J.R. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J. Biol. Chem. 2008, 283:6631-6639.
99. Taylor K., McCullough B., Clarke D.J., Langley R.J., Pechenick T., Hill A., Campopiano D.J., Barran P.E., Dorin J.R., Govan J.R. Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Antimicrob. Agents Chemother. 2007, 51:1719-1724.
100. Tuting T. The immunology of cutaneous DNA immunization. Curr. Opin. Mol. Ther. 1999, 1:216-225.
101. van Drunen Littel-van den H., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., McCartney D., Watts T., Babiuk L.A. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 1998, 79(Pt 4):831-839.
102. van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., van den Hurk J.V., Harland R., Babiuk L.A., Zamb T.J. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 1994, 12:1295-1302.
103. Vanbervliet B., Homey B., Durand I., Massacrier C., Ait-Yahia S., de Bouteiller O., Vicari A., Caux C. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 2002, 32:231-242.
104. Wakefield J.S., Gale J.S., Berridge M.V., Jordan T.W., Ford H.C. Is Percoll innocuous to cells?. Biochem. J. 1982, 202:795-797.
105. Wattegedera S., Sills K., Howard C.J., Hope J.C., McInnes C.J., Entrican G. Variability in cytokine production and cell proliferation by mitogen-activated ovine peripheral blood mononuclear cells: modulation by interleukin (IL)-10 and IL-12. Vet. Immunol. Immunopathol. 2004, 102:67-76.
106. Werling D., Collins R.A., Taylor G., Howard C.J. Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus. J. Leukoc. Biol. 2002, 72:297-304.
107. Werling D., Hope J.C., Chaplin P., Collins R.A., Taylor G., Howard C.J. Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J. Leukoc. Biol. 1999, 66:50-58.
108. Wilson N.S., Young L.J., Kupresanin F., Naik S.H., Vremec D., Heath W.R., Akira S., Shortman K., Boyle J., Maraskovsky E., Belz G.T., Villadangos J.A. Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol. Cell Biol. 2008, 86(2):200-205.
109. Wu Z., Hoover D.M., Yang D., Boulegue C., Santamaria F., Oppenheim J.J., Lubkowski J., Lu W. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8880-8885.
110. Yang D., Biragyn A., Hoover D.M., Lubkowski J., Oppenheim J.J. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 2004, 22:181-215.
111. Yang D., Chen Q., Chertov O., Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 2000, 68:9-14.
112. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286:525-528.
113. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:5449-5453.
114. Zhao C., Nguyen T., Liu L., Sacco R.E., Brogden K.A., Lehrer R.I. Gallinacin-3, an inducible epithelial beta-defensin in the chicken. Infect. Immun. 2001, 69:2684-2691.
115. Zhuang Y., Mwangi W., Brown W.C., Davis W.C., Hope J.C., Palmer G.H. Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen. Clin. Vaccine Immunol. 2006, 13:1064-1069.